Statera Biopharma, Inc. (STAB)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
May 9, 2025, 10:15 AM EDT
Statera Biopharma Market Cap
Statera Biopharma has a market cap or net worth of $7.26 thousand as of May 9, 2025. Its market cap has increased by 9,842.47% in one year.
Market Cap
7.26K
Enterprise Value
n/a
Revenue
3.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since July 28, 2021, Statera Biopharma's market cap has decreased from 170.15M to 7.26K, a decrease of -100.00%. That is a compound annual growth rate of -93.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 7.26K | - |
| Dec 31, 2024 | 7.26K | -83.33% |
| Dec 29, 2023 | 43.55K | -99.02% |
| Dec 30, 2022 | 4.44M | -93.99% |
| Dec 31, 2021 | 73.82M | -56.61% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.62B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 729.60M |
| Tian'an Technology Group | 568.98M |
| Glass House Brands | 485.08M |
| Elite Pharmaceuticals | 448.25M |
| CytoDyn | 401.33M |
| Northwest Biotherapeutics | 390.49M |